In a different study, miR-133a-3p was shown to act as a tumor suppressor and to inhibit the proliferation, differentiation, and motility of cancer cells via different mechanisms, such as targeting several oncogenes, targeting the EGFR/Akt signaling pathway, and inhibiting IGF1R expression [43,44,45]. This evidence concerns the gene IGF1R and neoplasm.